March 17th Show : Blog Of The Nation On today's show, Bear Stearns buy-out, "The Vision Thing," brain enhancement drugs, the state of the press.
NPR logo March 17th Show

March 17th Show

Top o' the morning to ya!! Lynn Neary will be the host on today's show (and tomorrow). And here's what's coming up!! (I wish I could write this all in green):

The lucky charm of St. Patrick's Day hasn't affected Wall Street, but a lot of green is certainly flying around. Bear Stearns, the fifth-largest investment bank, has been bought by JPMorgan Chase at $2 a share. As a result, the Federal Reserve will provide up to $30 billion to JPMorgan Chase to help it finance the purchase. The Fed will also cut interest rates on direct loans to banks to prevent a market meltdown. So what the heck does all this mean? We'll ask Mark Zandi, chief economist for Moody's about the buy-out deal and the possible affects it could have on small businesses. Then on our opinion page, Stephen Kuusisto talks about his piece, from last Friday's edition of The New York Times, in which he explains the ways visually impaired people are uniquely and extraordinarily qualified to hold leadership positions.

In our second hour, we'll talk about brain enhancement drugs. Pills like Ritalin and Adderall not only help people with conditions such as attention deficit disorder, they help students, teachers and professionals get a little brain boost as well. Guest Barbara Sahakian, professor of clinical neuropsychology at Cambridge University, has dubbed brain enhancers "the professor's little helper." Have you used brain enhancement drugs to help you perform more efficiently at school or work? Tell us your story. At the end of the hour, we'll talk to Tom Rosenstiel, director for The Project for Excellence in Journalism, about the just released report that analyzes the state of the news media.

Enjoy today! May the luck of the Irish be with you!!!